首页> 外文期刊>European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology >The neurotensin-1 receptor agonist PD149163 inhibits conditioned avoidance responding without producing catalepsy in rats.
【24h】

The neurotensin-1 receptor agonist PD149163 inhibits conditioned avoidance responding without producing catalepsy in rats.

机译:神经降压素1受体激动剂PD149163抑制条件回避反应,而不会在大鼠中产生僵直。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Agonists for neurotensin (NT)-1 receptors have produced antipsychotic-like effects in many animals, including reversal of prepulse inhibition deficits and psychostimulant-induced increases in spontaneous activity. The present study sought to provide a basic assessment of the putative antipsychotic effects of PD149163 in rats using a two way conditioned avoidance response task, which is highly validated for screening antipsychotic drugs, and an inclined grid assessment, which is used to assess extrapyramidal side effect liability. PD149163 (0.0625-8.0 mg/kg) significantly suppressed conditioned avoidance responding (CAR) following administration of a 1.0 or 8.0 mg/kg dose. PD149163 failed to significantly increase catalepsy scores. The typical antipsychotic drug haloperidol (0.01-1.0 mg/kg) significantly suppressed CAR at a 0.1, 0.3, and 1.0 mg/kg dose, and a significant increase in catalepsy scores was found at the 1.0 mg/kg dose. The atypical antipsychotic drug clozapine (2.5-10.0 mg/kg) also produced a significant inhibition of CAR, which occurred following administration of a 10.0 mg/kg dose. Clozapine failed to significantly increase catalepsy scores. Finally, D-amphetamine (1.0 mg/kg), serving as a negative control, failed to suppress CAR or increase catalepsy scores. These data further suggest that PD149163 may have atypical antipsychotic-like properties.
机译:神经降压素(NT)-1受体激动剂已在许多动物中产生了抗精神病样作用,包括逆转了前脉冲抑制功能的缺陷和精神刺激药引起的自发活动的增加。本研究试图通过双向条件回避反应任务(对筛查抗精神病药物进行高度验证)和倾斜网格评估(用于评估锥体束外副作用)为PD149163在大鼠中的假定抗精神病作用提供基础评估。责任。在施用1.0或8.0 mg / kg剂量后,PD149163(0.0625-8.0 mg / kg)显着抑制了条件回避反应(CAR)。 PD149163无法显着提高僵直评分。典型的抗精神病药物氟哌啶醇(0.01-1.0 mg / kg)在0.1、0.3和1.0 mg / kg剂量下可显着抑制CAR,在1.0 mg / kg剂量下可使僵直评分显着增加。非典型抗精神病药物氯氮平(2.5-10.0 mg / kg)也产生了对CAR的显着抑制作用,其在给药10.0 mg / kg剂量后发生。氯氮平未能显着增加僵直评分。最后,作为阴性对照的D-苯异丙胺(1.0 mg / kg)无法抑制CAR或增加僵直评分。这些数据进一步表明PD149163可能具有非典型的抗精神病药样性质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号